# Unity Software Inc.: financial statements, quarterly

U · NYSE · CIK 1810806 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/u.md) · [Financials](/companies/u/financials.md) · [Filings](/companies/u/filings.md) · [Insiders](/companies/u/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/u/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [544](/filings/0001810806-24-000227.md) | [609 d](/filings/0001810806-26-000011.md) | [460](/filings/0001810806-25-000095.md) | [449](/filings/0001810806-25-000151.md) | [447](/filings/0001810806-25-000169.md) | [457 d](/filings/0001810806-26-000011.md) | [435](/filings/0001810806-26-000032.md) | [441](/filings/0001810806-26-000043.md) | [471](/filings/0001810806-25-000169.md) | [503 d](/filings/0001810806-26-000011.md) | [508](/filings/0001810806-26-000032.md) | [546](/filings/0001810806-26-000043.md) |
| Cost of revenue | $m | [151](/filings/0001810806-24-000227.md) | [262 d](/filings/0001810806-26-000011.md) | [144](/filings/0001810806-25-000095.md) | [109](/filings/0001810806-25-000151.md) | [112](/filings/0001810806-25-000169.md) | [116 d](/filings/0001810806-26-000011.md) | [114](/filings/0001810806-26-000032.md) | [114](/filings/0001810806-26-000043.md) | [120](/filings/0001810806-25-000169.md) | [129 d](/filings/0001810806-26-000011.md) | [352](/filings/0001810806-26-000032.md) | [112](/filings/0001810806-26-000043.md) |
| Gross profit | $m | [393](/filings/0001810806-24-000227.md) | [348 d](/filings/0001810806-26-000011.md) | [316](/filings/0001810806-25-000095.md) | [340](/filings/0001810806-25-000151.md) | [334](/filings/0001810806-25-000169.md) | [342 d](/filings/0001810806-26-000011.md) | [321](/filings/0001810806-26-000032.md) | [327](/filings/0001810806-26-000043.md) | [350](/filings/0001810806-25-000169.md) | [374 d](/filings/0001810806-26-000011.md) | [157](/filings/0001810806-26-000032.md) | [435](/filings/0001810806-26-000043.md) |
| Research and development | $m | [240](/filings/0001810806-24-000227.md) | [265 d](/filings/0001810806-26-000011.md) | [283](/filings/0001810806-25-000095.md) | [209](/filings/0001810806-25-000151.md) | [215](/filings/0001810806-25-000169.md) | [218 d](/filings/0001810806-26-000011.md) | [221](/filings/0001810806-26-000032.md) | [215](/filings/0001810806-26-000043.md) | [244](/filings/0001810806-25-000169.md) | [250 d](/filings/0001810806-26-000011.md) | [254](/filings/0001810806-26-000032.md) | [278](/filings/0001810806-26-000043.md) |
| Operating income | $m | [(127)](/filings/0001810806-24-000227.md) | [(259) d](/filings/0001810806-26-000011.md) | [(375)](/filings/0001810806-25-000095.md) | [(129)](/filings/0001810806-25-000151.md) | [(127)](/filings/0001810806-25-000169.md) | [(124) d](/filings/0001810806-26-000011.md) | [(128)](/filings/0001810806-26-000032.md) | [(119)](/filings/0001810806-26-000043.md) | [(126)](/filings/0001810806-25-000169.md) | [(107) d](/filings/0001810806-26-000011.md) | [(351)](/filings/0001810806-26-000032.md) | [(32.2)](/filings/0001810806-26-000043.md) |
| Interest expense | $m | [6.2](/filings/0001810806-23-000181.md) | [6.2 d](/filings/0001810806-24-000053.md) | [6.0](/filings/0001810806-24-000098.md) | [5.8](/filings/0001810806-25-000151.md) | [5.8](/filings/0001810806-25-000169.md) | [5.8 d](/filings/0001810806-26-000011.md) | [5.9](/filings/0001810806-26-000032.md) | [6.0](/filings/0001810806-26-000043.md) | [6.0](/filings/0001810806-25-000169.md) | [6.0 d](/filings/0001810806-26-000011.md) | [6.0](/filings/0001810806-26-000032.md) | [6.0](/filings/0001810806-26-000043.md) |
| Income tax | $m | [7.8](/filings/0001810806-24-000227.md) | [9.7 d](/filings/0001810806-26-000011.md) | [(12.8)](/filings/0001810806-25-000095.md) | [0.9](/filings/0001810806-25-000151.md) | [6.9](/filings/0001810806-25-000169.md) | [2.1 d](/filings/0001810806-26-000011.md) | [2.2](/filings/0001810806-26-000032.md) | [2.4](/filings/0001810806-26-000043.md) | [9.4](/filings/0001810806-25-000169.md) | [(7.7) d](/filings/0001810806-26-000011.md) | [(7.0)](/filings/0001810806-26-000032.md) | [2.4](/filings/0001810806-26-000043.md) |
| Net income | $m | [(124)](/filings/0001810806-24-000227.md) | [(253) d](/filings/0001810806-26-000011.md) | [(291)](/filings/0001810806-25-000095.md) | [(126)](/filings/0001810806-25-000151.md) | [(125)](/filings/0001810806-25-000169.md) | [(123) d](/filings/0001810806-26-000011.md) | [(77.6)](/filings/0001810806-26-000032.md) | [(109)](/filings/0001810806-26-000043.md) | [(126)](/filings/0001810806-25-000169.md) | [(90.0) d](/filings/0001810806-26-000011.md) | [(348)](/filings/0001810806-26-000032.md) | [(23.6)](/filings/0001810806-26-000043.md) |
| Diluted EPS | $ per share | [(0.32)](/filings/0001810806-24-000227.md) | not reported | [(0.75)](/filings/0001810806-25-000095.md) | [(0.32)](/filings/0001810806-25-000151.md) | [(0.31)](/filings/0001810806-25-000169.md) | not reported | [(0.19)](/filings/0001810806-26-000032.md) | [(0.26)](/filings/0001810806-26-000043.md) | [(0.30)](/filings/0001810806-25-000169.md) | not reported | [(0.80)](/filings/0001810806-26-000032.md) | [(0.05)](/filings/0001810806-26-000043.md) |
| Basic EPS | $ per share | [(0.32)](/filings/0001810806-24-000227.md) | not reported | [(0.75)](/filings/0001810806-25-000095.md) | [(0.32)](/filings/0001810806-25-000151.md) | [(0.31)](/filings/0001810806-25-000169.md) | not reported | [(0.19)](/filings/0001810806-26-000032.md) | [(0.26)](/filings/0001810806-26-000043.md) | [(0.30)](/filings/0001810806-25-000169.md) | not reported | [(0.80)](/filings/0001810806-26-000032.md) | [(0.05)](/filings/0001810806-26-000043.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1,507](/filings/0001810806-23-000181.md) | [1,590](/filings/0001810806-25-000026.md) | [1,180](/filings/0001810806-24-000098.md) | [1,268](/filings/0001810806-24-000189.md) | [1,405](/filings/0001810806-24-000227.md) | [1,518](/filings/0001810806-26-000011.md) | [1,541](/filings/0001810806-25-000095.md) | [1,691](/filings/0001810806-25-000151.md) | [1,899](/filings/0001810806-25-000169.md) | [2,056](/filings/0001810806-26-000043.md) | [2,141](/filings/0001810806-26-000032.md) | [2,352](/filings/0001810806-26-000043.md) |
| Current assets | $m | [2,233](/filings/0001810806-23-000181.md) | [2,325](/filings/0001810806-25-000026.md) | [1,941](/filings/0001810806-24-000098.md) | [1,984](/filings/0001810806-24-000189.md) | [2,116](/filings/0001810806-24-000227.md) | [2,225](/filings/0001810806-26-000011.md) | [2,239](/filings/0001810806-25-000095.md) | [2,408](/filings/0001810806-25-000151.md) | [2,623](/filings/0001810806-25-000169.md) | [2,812](/filings/0001810806-26-000043.md) | [2,923](/filings/0001810806-26-000032.md) | [3,180](/filings/0001810806-26-000043.md) |
| Total assets | $m | [7,426](/filings/0001810806-23-000181.md) | [7,243](/filings/0001810806-25-000026.md) | [6,753](/filings/0001810806-24-000098.md) | [6,684](/filings/0001810806-24-000189.md) | [6,726](/filings/0001810806-24-000227.md) | [6,737](/filings/0001810806-26-000011.md) | [6,646](/filings/0001810806-25-000095.md) | [6,716](/filings/0001810806-25-000151.md) | [6,783](/filings/0001810806-25-000169.md) | [6,838](/filings/0001810806-26-000043.md) | [6,522](/filings/0001810806-26-000032.md) | [6,661](/filings/0001810806-26-000043.md) |
| Current liabilities | $m | [950](/filings/0001810806-23-000181.md) | [894](/filings/0001810806-25-000026.md) | [902](/filings/0001810806-24-000098.md) | [842](/filings/0001810806-24-000189.md) | [877](/filings/0001810806-24-000227.md) | [889](/filings/0001810806-26-000011.md) | [818](/filings/0001810806-25-000095.md) | [883](/filings/0001810806-25-000151.md) | [942](/filings/0001810806-25-000169.md) | [1,526](/filings/0001810806-26-000043.md) | [1,501](/filings/0001810806-26-000032.md) | [1,570](/filings/0001810806-26-000043.md) |
| Total liabilities | $m | [3,960](/filings/0001810806-23-000181.md) | [3,829](/filings/0001810806-25-000026.md) | [3,339](/filings/0001810806-24-000098.md) | [3,267](/filings/0001810806-24-000189.md) | [3,299](/filings/0001810806-24-000227.md) | [3,310](/filings/0001810806-26-000011.md) | [3,219](/filings/0001810806-25-000095.md) | [3,282](/filings/0001810806-25-000151.md) | [3,329](/filings/0001810806-25-000169.md) | [3,341](/filings/0001810806-26-000043.md) | [3,281](/filings/0001810806-26-000032.md) | [3,354](/filings/0001810806-26-000043.md) |
| Shareholders' equity | $m | [3,242](/filings/0001810806-23-000181.md) | [3,183](/filings/0001810806-25-000026.md) | [3,184](/filings/0001810806-24-000098.md) | [3,185](/filings/0001810806-24-000189.md) | [3,184](/filings/0001810806-24-000227.md) | [3,191](/filings/0001810806-26-000011.md) | [3,186](/filings/0001810806-25-000095.md) | [3,187](/filings/0001810806-25-000151.md) | [3,203](/filings/0001810806-25-000169.md) | [3,237](/filings/0001810806-26-000043.md) | [2,976](/filings/0001810806-26-000032.md) | [3,034](/filings/0001810806-26-000043.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [120 d](/filings/0001810806-24-000227.md) | [72.1 d](/filings/0001810806-26-000011.md) | [(7.4)](/filings/0001810806-25-000095.md) | [88.4 d](/filings/0001810806-25-000151.md) | [122 d](/filings/0001810806-25-000169.md) | [112 d](/filings/0001810806-26-000011.md) | [13.0](/filings/0001810806-26-000032.md) | [133 d](/filings/0001810806-26-000043.md) | [155 d](/filings/0001810806-25-000169.md) | [121 d](/filings/0001810806-26-000011.md) | [71.3](/filings/0001810806-26-000032.md) | [206 d](/filings/0001810806-26-000043.md) |
| Capital expenditure | $m | [16.1 d](/filings/0001810806-24-000227.md) | [11.4 d](/filings/0001810806-26-000011.md) | [7.2](/filings/0001810806-25-000095.md) | [8.8 d](/filings/0001810806-25-000151.md) | [7.2 d](/filings/0001810806-25-000169.md) | [6.4 d](/filings/0001810806-26-000011.md) | [5.7](/filings/0001810806-26-000032.md) | [6.4 d](/filings/0001810806-26-000043.md) | [4.1 d](/filings/0001810806-25-000169.md) | [2.8 d](/filings/0001810806-26-000011.md) | [4.8](/filings/0001810806-26-000032.md) | [3.7 d](/filings/0001810806-26-000043.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001810806-26-000011.md) | not reported | not reported | not reported | [0.0 d](/filings/0001810806-26-000011.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [299](/filings/0001810806-23-000181.md) | [376](/filings/0001810806-24-000098.md) | [380](/filings/0001810806-24-000189.md) | [384](/filings/0001810806-24-000227.md) | [387](/filings/0001810806-25-000095.md) | [393](/filings/0001810806-25-000151.md) | [399](/filings/0001810806-25-000169.md) | [412](/filings/0001810806-26-000032.md) | [418](/filings/0001810806-26-000043.md) | [424](/filings/0001810806-25-000169.md) | [434](/filings/0001810806-26-000032.md) | [438](/filings/0001810806-26-000043.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 440,088,933 at 2026-07-29, from the cover of the [10-Q filed 2026-08-06](/filings/0001810806-26-000043.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.